Deals

circle
Biotech

BMS inks $1.5B deal to pull Orbital into its sphere of influence

Pushing deeper into in vivo cell therapies, BMS has struck a deal to buy Orbital and its pipeline led by a preclinical CD19 autoimmune program.
Nick Paul Taylor Oct 10, 2025 8:45am
Space shuttle takes off on background of blue sky

Shuttle Pharma launches into AI drug discovery via $10M buy

Oct 10, 2025 7:00am
Closeup of blue eye on black background

AviadoBio secures option to rare eye disease gene therapy

Oct 9, 2025 8:50am
Graphic of two hands shaking under a red and purple light

Novo inks $4.7B Akero buyout to bag late-phase MASH prospect

Oct 9, 2025 8:21am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

CDMO Catalent strengthens ADC pipeline with $10M Lisata pact

Oct 9, 2025 7:45am
Three blocks displaying from left to right a person a handshake and another person

BD, Opentrons Labs enter collaboration to join tech offerings

Oct 8, 2025 2:07pm